You are viewing: China Dental Soft-Tissue Regeneration Market analysis

The China Dental Soft-Tissue Regeneration Market was valued at $2.88 Million in 2024 and projected to reach to $4.78 Million by 2029, representing a compound annual growth rate of 10.7%. China's dental soft-tissue regeneration market is positioned for sustained growth, expanding from USD 2.88 million in 2024 to USD 4.78 million by 2029.

China Dental Soft-Tissue Regeneration Market (2024-2029) : Size and Share
logo-mobile
CAGR of
cagr-Chart
USD Million
MARKET SNAPSHOT
Market Size in USD 26.32 MN
Market Forecast in
CAGR
Forecast Period
Units Considered Value (USD MN)

China Dental Soft-Tissue Regeneration Market Trends and Insights

  • This growth trajectory reflects China's increasing investment in advanced dental technologies and rising patient demand for minimally invasive periodontal treatments.
  • China's market is expanding faster than the global average, driven by urbanization, improved healthcare infrastructure, and growing awareness of oral health among middle-class consumers. The dental soft-tissue regeneration sector in China benefits from strong government support for healthcare innovation and a large patient population requiring periodontal interventions.
  • China's adoption of regenerative biomaterials and guided tissue regeneration (GTR) techniques is accelerating as dental practitioners seek advanced solutions for gum recession and bone loss.
  • Between 2024 and 2029, China is expected to capture significant market share within the Asia Pacific region, supported by increasing clinical adoption and favorable reimbursement policies. China's competitive landscape includes both domestic manufacturers and international players establishing local partnerships.
  • The market's 10.7% compound annual growth rate underscores China's position as a high-growth market within the global dental soft-tissue regeneration industry, reflecting the country's commitment to modernizing dental care delivery..

Key Market Statistics

  • CAGR (2024-2029) 10.7% CAGR
  • Market Size, 2024 ~USD 2.88 Million
  • Forecast, 2029 ~USD 4.78 Million
  • Country China

China Dental Soft-Tissue Regeneration Market Overview

Rapid Market Expansion :

China's dental soft-tissue regeneration market is growing at 10.7% CAGR, significantly outpacing the global average of 7.8%, reflecting strong domestic demand and technological adoption.

Rising Periodontal Treatment Demand :

Increasing prevalence of periodontal diseases among China's aging population and growing awareness of minimally invasive treatments are driving market growth and patient engagement.

Government Investment in Dental Technology :

China's healthcare modernization initiatives and substantial R&D investments in advanced dental regeneration technologies are accelerating market development and clinical adoption.

Urban Healthcare Infrastructure Growth :

Expansion of dental clinics and hospitals in tier-1 and tier-2 Chinese cities, coupled with rising disposable incomes, is creating robust demand for premium soft-tissue regeneration solutions.

China Dental Soft-Tissue Regeneration Market Dynamics

  • This trajectory is underpinned by increasing healthcare spending, growing patient awareness of periodontal health, and rapid adoption of advanced regenerative technologies among Chinese dental practitioners.
  • The market benefits from China's emphasis on preventive dentistry and cosmetic dental procedures. Key growth drivers include an aging demographic requiring periodontal interventions, rising middle-class populations seeking premium dental care, and government support for healthcare innovation.
  • Strategic partnerships between international dental companies and Chinese healthcare providers are facilitating technology transfer and market penetration, positioning China as a critical growth market within the Asia-Pacific region..

Related Ecosystem

Medical Devices

Top Technologies
  • Polymerase Chain Reaction (PCR)
  • Magnetic Resonance Imaging (MRI)
  • Disposable Autoinjectors
  • Pulse Oximeters
  • Blood Pressure Monitors
Top Companies
  • Medtronic plc
  • Abbott Laboratories
  • Stryker Corporation
  • Becton, Dickinson and Company
  • JOHNSON & JOHNSON

    Key Takeaways

    • China's dental soft-tissue regeneration market is valued at USD 2.88 million in 2024 and is forecast to grow to USD 4.78 million by 2029, representing a 10.7% CAGR.
    • China's market growth rate significantly outpaces the global average of 7.8%, driven by urbanization, healthcare modernization, and rising oral health awareness.
    • China's adoption of advanced regenerative biomaterials and GTR techniques is accelerating due to increasing clinical demand and supportive government healthcare policies.
    • China's competitive landscape is characterized by both domestic innovation and international partnerships, positioning the country as a key growth engine in the Asia Pacific region.

    Dental Soft-Tissue Regeneration Market Report Scope

    Report Metric Details
    Base Year 2024
    Fastest Growing Segment PERIODONTOLOGY (Application)
    Forecast Period 2024–2029
    Growth Rate CAGR of 7.8% from 2024 to 2029
    Largest Segment AUTOGRAFTS (Product Type)
    Market Size Base Year (Billions) ~USD 0.34 (2024)
    Revenue Forecast (Billions) ~USD 0.54 (2029)
    Segments Covered Product Type, Application, End User

    China Dental Soft-Tissue Regeneration Market Report Segmentation

    3 segment dimensions are covered across the global market.

    By Product Type

    • Autografts
    • Collagen-Based Membranes
    • Other Products
    • Synthetic Biomaterials

    By Application

    • Implantology
    • Other Applications
    • Periodontology

    By End User

    • Academic & Research Institutes
    • Dental Hospitals
    • Dsos & Independent Clinics

    CHINA: DENTAL SOFT-TISSUE REGENERATION MARKET, BY END USER, 2022–2029

    Segment20222023202420252026202720282029CAGR (%)
    ACADEMIC & RESEARCH INSTITUTES0.320.330.340.350.370.390.410.455.7
    DENTAL HOSPITALS1.41.471.561.671.81.972.162.419.1
    DSOS & INDEPENDENT CLINICS2.642.813.033.293.613.994.455.0310.7
    TOTAL4.354.64.935.325.786.347.037.899.9

    Target Audience

    • Dental Device Manufacturers : Manufacturers need China-specific market data to develop localized product strategies, navigate regulatory pathways, and identify distribution partnerships in this rapidly expanding market.
    • Healthcare Investment Firms : Investment professionals require detailed market sizing, growth projections, and competitive analysis to evaluate investment opportunities and portfolio companies operating in China's dental sector.
    • Dental Practice Operators : Clinic owners and dental practitioners need market insights to make informed decisions about adopting soft-tissue regeneration technologies and understanding patient demand trends in China.
    • Pharmaceutical and Biotech Companies : Companies developing regenerative materials and biologics require China-specific market intelligence to assess commercialization potential and develop go-to-market strategies for this region.
    • Healthcare Consultants and Advisors : Consultants advising healthcare organizations need comprehensive China market data to provide strategic recommendations on market entry, competitive positioning, and growth opportunities.

    Key Companies in the China Dental Soft-Tissue Regeneration Market

    CompanyHQOwnershipStrongest segments
    HENRY SCHEIN, INC.United StatesPublic CompanyAutografts,Synthetic Biomaterials,Collagen-based Membranes,
    ENVISTAUnited StatesPublic CompanyAutografts,Synthetic Biomaterials,Collagen-based Membranes,
    ZIMVIE INC.United StatesPrivate CompanyAutografts,Synthetic Biomaterials,Collagen-based Membranes,
    DENTSPLY SIRONA INC.United StatesPublic CompanyAutografts,Synthetic Biomaterials,Collagen-based Membranes,
    ABBVIE INC.United StatesPublic CompanyAutografts,Synthetic Biomaterials,Collagen-based Membranes,
    ADVANCED MEDICAL SOLUTIONS GROUP PLCUnited KingdomPublic CompanyCollagen-based Membranes,Synthetic Biomaterials,Autografts,
    TISSUE REGENIXUnited KingdomPrivate CompanyAutografts,Synthetic Biomaterials,Collagen-based Membranes,
    MECCELLIS BIOTECHFranceCollagen-based Membranes,Synthetic Biomaterials,Autografts,

    HENRY SCHEIN, INC.

    Henry Schein, Inc. is a publicly traded American company founded in 1932 with approximately 25,000 employees. It is a leading global distributor of dental, medical, and veterinary products and services.

    ENVISTA

    Envista is a publicly traded American company founded in 2018 with approximately 12,000 employees. The company operates as a global provider of dental products, technologies, and services.

    ZIMVIE INC.

    Zimvie Inc. is a privately held American company founded in 2021 with approximately 1,770 employees. The company focuses on dental implants, bone regeneration, and related surgical solutions.

    DENTSPLY SIRONA INC.

    Dentsply Sirona Inc. is a publicly traded American company founded in 2015. The company is a leading manufacturer and distributor of dental products, technologies, and equipment.

    ABBVIE INC.

    AbbVie Inc. is a publicly traded American pharmaceutical company founded in 2012 with approximately 57,000 employees. The company develops and markets a broad range of pharmaceutical products across multiple therapeutic areas.

    ADVANCED MEDICAL SOLUTIONS GROUP PLC

    Advanced Medical Solutions Group PLC is a publicly traded British company founded in 1991 with approximately 1,800 employees. The company specializes in advanced wound care and surgical solutions.

    TISSUE REGENIX

    Tissue Regenix is a privately held British company founded in 2006 with approximately 92 employees. The company develops regenerative medicine and advanced wound care products.

    MECCELLIS BIOTECH

    Meccellis Biotech is a French company founded in 2011 that operates in the biotechnology sector. The company focuses on regenerative medicine and cellular therapy solutions.

    Reasons to Buy this Report

    • Market-Specific Growth Intelligence : Gain detailed insights into China's 10.7% CAGR trajectory and understand the unique drivers differentiating this market from global trends, enabling targeted investment and expansion strategies.
    • Competitive Landscape Analysis : Identify key players, market consolidation patterns, and competitive positioning specific to China's dental soft-tissue regeneration sector to inform market entry and partnership strategies.
    • Regulatory and Reimbursement Pathways : Access China-specific regulatory requirements, approval processes, and reimbursement frameworks essential for product commercialization and market success in this high-growth region.
    • Customer Segmentation and Demand Drivers : Understand China's patient demographics, treatment preferences, and purchasing behaviors to tailor product offerings and marketing strategies for maximum market penetration and ROI.
    • Investment and Partnership Opportunities : Identify strategic investment opportunities, joint venture prospects, and distribution partnerships with established Chinese dental providers to accelerate market entry and revenue growth.

    Frequently asked questions

    What is the current market size of dental soft-tissue regeneration in China?

    China's dental soft-tissue regeneration market was valued at USD 2.88 million in 2024 and is expected to grow to USD 4.78 million by 2029.

    What is the projected growth rate for China's dental soft-tissue regeneration market?

    China's market is projected to grow at a compound annual growth rate (CAGR) of 10.7% from 2024 to 2029, outpacing the global average of 7.8%.

    What factors are driving growth in China's dental soft-tissue regeneration market?

    Key drivers include urbanization, improved healthcare infrastructure, rising oral health awareness among middle-class consumers, government support for healthcare innovation, and increasing adoption of advanced regenerative techniques.

    How does China's market compare to the global dental soft-tissue regeneration market?

    China's market is growing faster than the global average, with a 10.7% CAGR compared to the global 7.8% CAGR, reflecting China's position as a high-growth market within the Asia Pacific region.

    What types of products and technologies are driving China's dental soft-tissue regeneration market?

    China's market growth is driven by regenerative biomaterials, guided tissue regeneration (GTR) techniques, and minimally invasive periodontal treatment solutions that address gum recession and bone loss.

    RESEARCH METHODOLOGY

    This study involved four key activities to estimate the current size of the dental soft-tissue regeneration market. First, extensive secondary research was conducted to gather information about the market, as well as related markets and the overall parent market. Next, the findings, assumptions, and estimates were validated through primary research conducted with industry experts across the value chain. Both top-down and bottom-up approaches were utilized to determine the overall market size. Finally, market breakdown and data triangulation techniques were employed to estimate the sizes of various segments and subsegments.

    Secondary Research

    The secondary research process utilized a variety of sources, including directories and databases such as Bloomberg Business, Factiva, and D&B Hoovers, as well as white papers, annual reports, company documents, investor presentations, and SEC filings. This method was employed to gather information relevant to a comprehensive, technical, market-focused, and commercial analysis of the dental soft-tissue regeneration market. It also helped obtain crucial details about key players in the industry, market classification, and segmentation based on current trends, extending down to the most granular levels. Additionally, important developments related to market and technological perspectives were captured. A database of key industry leaders was created using the information collected through secondary research.

    Primary Research

    In the primary research process, a variety of sources from both the supply and demand sides were interviewed to gather qualitative and quantitative information for this report. On the supply side, primary sources included industry experts such as CEOs, vice presidents, marketing and sales directors, technology and innovation directors, and other key executives from important companies and organizations operating in the dental soft-tissue regeneration market. On the demand side, primary sources consisted of industry experts, purchasing and sales managers, doctors, and personnel from research organizations. This primary research aimed to validate market segmentation, identify key players, and collect insights on major industry trends and market dynamics.

    A breakdown of the primary respondents for the dental soft-tissue regeneration market is provided below:

    Dental Soft-tissue Regeneration Market

    Note 1: C-level executives include CEOs, CFOs, COOs, and VPs.

    Note 2: Others include sales managers, marketing managers, business development managers, product managers, distributors, and suppliers.

    Note 3: Companies are classified into tiers based on their total revenue. As of 2024, Tier 1 = >USD 10.00 billion, Tier 2 = USD 1.00 billion to USD 10.00 billion, and Tier 3 = < USD 1.00 billion.

    Source: MarketsandMarkets Analysis

    To know about the assumptions considered for the study, download the pdf brochure

    Market Size Estimation

    For the global market value, annual revenues were calculated based on the revenue mapping of major product manufacturers and OEMs active in the global dental soft-tissue regeneration market. All the major product manufacturers were identified at the global and/or country/regional level. Revenue mapping for the respective business segments/sub-segments was done for the major players. Also, the global dental soft-tissue regeneration market was split into various segments and subsegments based on:

    • List of major players operating in the products market at the regional and/or country level
    • Product mapping of various dental soft-tissue regeneration manufacturers at the regional and/or country level
    • Mapping of annual revenue generated by listed major players from dental soft-tissue regenerative products (or the nearest reported business unit/product category)
    • Revenue mapping of major players to cover at least 70–75% of the global market share as of 2023
    • Extrapolation of the revenue mapping of the listed major players to derive the global market value of the respective segments/subsegments
    • Summation of the market value of all segments/subsegments to arrive at the global diagnostics market

    The above-mentioned data was consolidated and added with detailed inputs and analysis from MarketsandMarkets and presented in this report.

    Market Size Estimation (Bottom-up Approach & Top-down Approach)

    Dental Soft-tissue Regeneration Market

    Data Triangulation

    After arriving at the overall size of the global dental soft-tissue regeneration market through the above-mentioned methodology, this market was split into several segments and subsegments. Where applicable, the data triangulation and market breakdown procedures were employed to complete the overall market engineering process and arrive at the exact market value data for the key segments and subsegments. The extrapolated market data was triangulated by studying various macroindicators and regional trends from both demand- and supply-side participants.

    Market Definition

    Dental soft-tissue regeneration involves restoring or reconstructing soft tissues, including the gums and connective tissues surrounding the teeth. This process seeks to facilitate the healing of tissues lost due to gum disease or trauma to enhance the health and aesthetic appearance of the gums and their functionality. These procedures can be effectively used in the treatment of gum recession, tissue defects around the implants, or any other soft-tissue defects, and eventually, to improve the smile.

    Stakeholders

    • Dental soft-tissue regenerative material manufacturing companies
    • Distributors and suppliers of dental soft-tissue regeneration products
    • Medical device companies
    • Research and consulting firms
    • Healthcare institutions (hospitals, laboratories, medical schools, and outpatient clinics)
    • Research institutes and academic centers
    • Contract research organizations (CROs)
    • Government associations
    • Venture capitalists and investors

    Report Objectives

    • To define, describe, and forecast the dental soft-tissue regeneration market based on product type, application, end user, and region
    • To forecast the market size based on six key regions: North America, Europe, Asia Pacific, Latin America, the Middle East & Africa, and GCC Countries
    • To strategically analyze the industry trends, technology trends, pricing analysis, regulatory scenario, supply/value chain, ecosystem mapping, Porter’s five forces, patent analysis, key stakeholders and buying criteria, and conference and events
    • To provide detailed information regarding the major factors influencing the growth of this market (such as drivers, restraints, opportunities, and challenges)
    • To analyze the micromarkets with respect to individual growth trends, prospects, and contributions to the overall dental soft-tissue regeneration market
    • To analyze the opportunities for stakeholders and provide details of the competitive landscape for market leaders
    • To strategically profile key players in the dental soft-tissue regeneration market and comprehensively analyze their core competencies
    • To track and analyze competitive developments such as product launches & approvals, partnerships, agreements, collaborations, joint ventures, expansions, and acquisitions in the overall dental soft-tissue regeneration market
    • To benchmark players within the market using the proprietary “Company Evaluation Matrix” framework, which analyzes market players on various parameters within the broad categories of business and product/service strategy
    • To analyze the generative AI impact on the dental soft-tissue regeneration market

    Get the Full Dental Soft-Tissue Regeneration Market Report

    Full forecast, segment splits, and company analysis for all Dental Soft-Tissue Regeneration Market.

    Need a Tailored Report?

    Customize this report to your needs

    Get 10% FREE Customization

    Customize This Report
    Fact checked
    DMCA.com Protection Status